Author

Peter A. Riedell

University of ChicagoORCID 0000-0003-2719-0580Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Erting TangiD· 2 shared Guoshuai CaoiD· 2 shared Jun HuangiD· 2 shared Justin Paul KlineiD· 2 shared Michael Russell BishopiD· 2 shared Nicholas W. AsbyiD· 2 shared Yifei HuiD· 2 shared Duy-Thuc NguyeniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Erting TangORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyCancer Immunology ResearchPeer-reviewedMay 8, 2026

Low-Strength Type I Interferon Signaling Promotes CAR T-Cell Treatment Efficacy

Erting Tang, Yifei Hu, Guoshuai Cao…·Jun Huang

This study shows that low-strength type I interferon signaling enhances CAR T-cell efficacy against B-cell lymphoma and leukemia without causing in vivo toxicity.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologyNature CommunicationsPeer-reviewedMay 6, 2025

Two-Stage CD8+ CAR T-Cell Differentiation in Patients with Large B-Cell Lymphoma

Guoshuai Cao, Yifei Hu, Tony Pan…·Jun Huang

This study identifies two distinct waves of CD8+ CAR T-cell differentiation in DLBCL patients, showing they originate from different precursor populations with distinct phenotypes and ontogenies.

16 citationstop 2%

humanscRNA-seq

𝕏 PostBluesky